Edition:
United States

Anhui Anke Biotechnology Group Co Ltd (300009.SZ)

300009.SZ on Shenzhen Stock Exchange

19.90CNY
--
Change (% chg)

-- (--)
Prev Close
¥19.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,111,112
52-wk High
¥30.40
52-wk Low
¥18.12

Latest Key Developments (Source: Significant Developments)

Anhui Anke Biotechnology Group unit gets CEP for drug OXYTOCIN from EDQM
Wednesday, 19 Apr 2017 11:36pm EDT 

April 20 (Reuters) - Anhui Anke Biotechnology Group Co Ltd <300009.SZ> ::* Says its wholly owned subsidiary Shanghai SOHO-YIMING Pharmaceuticals Co Ltd got Certificate of Suitability to Monograph of European Pharmacopoeia (CEP) for the drug oxytocin API(OXYTOCIN) from European Directorate for Quality of Medicines & HealthCare (EDOM).* Oxytocin API(OXYTOCIN) is used for treatment of uterine bleeding after induction of labor.  Full Article

Anhui Anke Biotechnology Group to set up health industry investment LP with partners
Thursday, 30 Mar 2017 06:00am EDT 

Anhui Anke Biotechnology Group Co Ltd <300009.SZ> : Says it plans to set up health industry investment LP with partners .Says the size of the fund is about 1 billion yuan.  Full Article

Anhui Anke Biotechnology Group unit to set up health industry JV with partners
Thursday, 30 Mar 2017 04:49am EDT 

Anhui Anke Biotechnology Group Co Ltd <300009.SZ> :Says co's wholly owned unit plans to invest 10 million yuan to set up health industry investment LP with partners and will hold a 49.3097 percent stake in it.  Full Article

Anhui Anke Biotechnology Group announces FY 2016 dividend payment
Thursday, 30 Mar 2017 04:49am EDT 

Anhui Anke Biotechnology Group Co Ltd <300009.SZ> : To use undistributed profits to pay a cash dividend of 1.5 yuan (pre-tax) per 10 shares to shareholders for FY 2016 .To use additional paid-in capital to distribute 3 new shares for every 10 shares.  Full Article

Anhui Anke Biotechnology Group sees FY 2017 Q1 net profit to increase by 13.6 pct to 42 pct
Wednesday, 29 Mar 2017 04:55am EDT 

Anhui Anke Biotechnology Group Co Ltd <300009.SZ> : Says net profit for FY 2017 Q1 to increase by 13.6 percent to 42 percent, or to be 40 million yuan to 50 million yuan, compared to net profit of FY 2016 Q1 (35.2 million yuan) .Says increased revenue and enhancement of internal police discipline as main reasons for the forecast.  Full Article

Anhui Anke Biotechnology Group unit receives GMP certificate
Thursday, 9 Feb 2017 10:45pm EST 

Anhui Anke Biotechnology Group Co Ltd <300009.SZ> :Says its pharmacy unit received goods manufacture practice (GMP) certificate from Anhui Food and Drug Administration.  Full Article

Anhui Anke Biotechnology (Group) sees FY 2016 net profit up 11 pct to 25 pct
Friday, 27 Jan 2017 04:00am EST 

Anhui Anke Biotechnology Group Co Ltd <300009.SZ> : Sees FY 2016 net profit to increase by 11 percent to 25 percent, or to be 26 million yuan to 29.3 million yuan . Says FY 2015 net profit was 23.4 million yuan .The reasons are turnaround of traditional coal mine business and transformation of subsidiary.  Full Article

Anhui Anke Biotechnology Group plans gene tech JV with partner
Wednesday, 16 Nov 2016 12:21am EST 

Anhui Anke Biotechnology Group Co Ltd <300009.SZ> : Says it plans to set up a gene tech JV in Hefei city, with an individual Pu Yi .Says JV's registered capital is 50 million yuan and co will hold a 40 percent stake in it.  Full Article

Anhui Anke Biotechnology (Group) plans cell tech JV with PersonGen Biomedicine (Suzhou)
Friday, 28 Oct 2016 05:28am EDT 

Anhui Anke Biotechnology (Group) Co Ltd <300009.SZ> : Says it enters into a cooperation agreement to set up a cell technology JV with PersonGen Biomedicine (Suzhou) Co Ltd .Says JV with registered capital of 100 million yuan and co will hold a 49 percent stake in it.  Full Article

Anhui Anke Biotechnology sees 2016 Q1 to Q3 net profit up 27.6-38.6 pct
Monday, 17 Oct 2016 03:05am EDT 

Anhui Anke Biotechnology (Group) Co., Ltd. <300009.SZ> : Sees net profit for Q1 to Q3 of 2016 to increase by 27.6 percent to 38.6 percent , or to be 139 million yuan to 151 million yuan . Says the net profit of Q1 to Q3 of 2015 was 108.9 million yuan .Comments that strengthened internal management and market development, as well as involved performance of two newly acquired companies are the main reasons for the forecast.  Full Article

More From Around the Web

BRIEF-Anhui Anke Biotechnology Group unit gets CEP for drug OXYTOCIN from EDQM

* Says its wholly owned subsidiary Shanghai SOHO-YIMING Pharmaceuticals Co Ltd got Certificate of Suitability to Monograph of European Pharmacopoeia (CEP) for the drug oxytocin API(OXYTOCIN) from European Directorate for Quality of Medicines & HealthCare (EDOM)